Try our corporate solution for free!

Pharmaceutical industry financial penalties - United States 1991-2017

Pharmaceutical industry financial penalties in the United States from 1991 to 2017 (in million U.S. dollars)*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

March 2018


United States

Survey time period

1991 to 2017

Supplementary notes

* From settlements between the federal and state governments and pharmaceutical manufacturers.

An additional multi-state settlement, reached in 2016 with Teva’s Cephalon subsidiary for monopoly practices, involved a $125 million civil monetary fine. However, the entirety of this fine was paid from a previous (2015) $1.2 billion civil settlement payment by Teva’s Cephalon subsidiary to the federal government. Because this $1.2 billion federal financial penalty already was included in our database, we did not include the $125 million multi-state settlement payment so as not to count Teva’s settlement payment twice.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical and medical device recalls in the U.S."

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.